Spain Genetic Testing Market Size & Outlook, 2025-2033

Spain Genetic Testing Market Insights

As highlighted in Reed Intelligence analysis, the Spain Genetic Testing Market, worth USD 384.04 Million in 2024, is forecasted to achieve USD 932.73 Million by 2033.
The Spain market is anticipated to grow at a CAGR of 10.27% during the period 2026–2033.
By 2024, Predictive Testing & Presymptomatic Testing represented the largest share of the By Type market size.
Predictive Testing & Presymptomatic Testing is expected to remain the key growth driver within By Type, registering the fastest CAGR during the forecast period.

Other Key Findings

In 2024, Spain accounted for 1.95% of the global Genetic Testing Market size.
By 2033, United States is expected to lead the global Genetic Testing Market in terms of market size.
Within Europe, Germany is projected to dominate the regional Genetic Testing Market size by 2033.
Russia is identified as the fastest-growing market in Europe, anticipated to reach USD 934.42 Million by 2033.

Report Summary

Report Scope	Details
Base Year for Study	2024
Study Period	2021-2033
Historical Period	2021-2023
Forecast Period	2025-2033
Market Size In 2024	USD 384.04 Million
Market Size In 2033	USD 932.73 Million
Largest segment	Predictive Testing & Presymptomatic Testing
Units	Revenue in USD Million
CAGR	10.27% (2025-2033)
Segmnetation Covered
By Type	Predictive Testing & Presymptomatic Testing Carrier Testing Prenatal & Newborn Testing Diagnostic Testing Pharmacogenomic Testing Others
By Technique	Polymerase chain reaction (PCR) DNA Sequencing Cytogenetics Microarrays Others
By Application	Oncology Cardiovascular Disease Diagnosis Neurological Disorders Genetic Disorders Others
By End User	Hospitals & Clinics Diagnostic Laboratories Others
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Spain Genetic Testing Market By Type 2025-2033 (USD Million)

By Type	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Predictive Testing & Presymptomatic Testing	XX.x	XX.x	XX.x	120.28	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Carrier Testing	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Prenatal & Newborn Testing	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Diagnostic Testing	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Pharmacogenomic Testing	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Others	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Spain Genetic Testing Market By Technique 2025-2033 (USD Million)

By Technique	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Polymerase chain reaction (PCR)	XX.x	XX.x	XX.x	134.41	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
DNA Sequencing	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Cytogenetics	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Microarrays	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Others	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Spain Genetic Testing Market By Application 2025-2033 (USD Million)

By Application	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Oncology	XX.x	XX.x	XX.x	135.91	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Cardiovascular Disease Diagnosis	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Neurological Disorders	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Genetic Disorders	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Others	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Spain Genetic Testing Market By End User 2025-2033 (USD Million)

By End User	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Hospitals & Clinics	XX.x	XX.x	XX.x	196.39	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Diagnostic Laboratories	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Others	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.